These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14509406)

  • 1. Fusidic acid-induced leukopenia and thrombocytopenia.
    Liao YM; Chiu CF; Ho MW; Hsueh CT
    J Chin Med Assoc; 2003 Jul; 66(7):429-32. PubMed ID: 14509406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusidic acid induced acute immunologic thrombocytopenia.
    El-Kassar N; Kalfon P; Fromont P; Vezinet C; Godeau B; Duedari N; Bierling P
    Br J Haematol; 1996 May; 93(2):427-31. PubMed ID: 8639443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukopenia and thrombocytopenia due to fusidic acid.
    Leibowitz G; Golan D; Yeshurun D; Brezis M
    Postgrad Med J; 1991 Jun; 67(788):591-2. PubMed ID: 1924043
    [No Abstract]   [Full Text] [Related]  

  • 4. Fusidic acid adverse drug reactions.
    Christiansen K
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S3-9. PubMed ID: 10528781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neutropenia during treatment with fusidic acid: analysis of 5 cases].
    Vial T; Gontier D; Pinède L; Cance P; Pofilet C; Evreux JC
    Therapie; 1995; 50(5):447-50. PubMed ID: 8571283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatotoxicity and hematologic complications induced by fusidic acid in a patient with hepatitis B cirrhosis: A case report.
    He ZF; Chen L; Zhang JP; Wang QQ
    Medicine (Baltimore); 2019 Nov; 98(45):e17852. PubMed ID: 31702645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sideroblastic anaemia during fusidic acid treatment.
    Vial T; Grignon M; Daumont M; Guy C; Zenut M; Germain ML; Jaubert J; Ruivard M; Guyotat D; Descotes J
    Eur J Haematol; 2004 May; 72(5):358-60. PubMed ID: 15059072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety record of fusidic acid in non-US markets: a focus on skin infections.
    Kraus CN; Burnstead BW
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S527-37. PubMed ID: 21546630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhabdomyolysis after co-administration of a statin and fusidic acid: an analysis of the literature and of the WHO database of adverse drug reactions.
    Deljehier T; Pariente A; Miremont-Salamé G; Haramburu F; Nguyen L; Rubin S; Rigothier C; Théophile H
    Br J Clin Pharmacol; 2018 May; 84(5):1057-1063. PubMed ID: 29337401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility testing and clinical effect of fusidic acid in oxacillin-resistant Staphylococcus aureus infections.
    Liu CP; Lee CM; Su SC; Li YT
    J Microbiol Immunol Infect; 1999 Sep; 32(3):194-8. PubMed ID: 10637718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study between teicoplanin alone and flucloxacillin, plus or minus fusidic acid, in the treatment of serious infections caused by methicillin-susceptible gram-positive bacteria.
    Mehtar S; Drabu Y; Wilson AP; Grüneberg RN
    Chemotherapy; 1995; 41(5):412-9. PubMed ID: 8521744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presumed interaction of fusidic acid with simvastatin.
    Burtenshaw AJ; Sellors G; Downing R
    Anaesthesia; 2008 Jun; 63(6):656-8. PubMed ID: 18477279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for ganciclovir-induced thrombocytopenia and leukopenia.
    Matsumoto K; Shigemi A; Ikawa K; Kanazawa N; Fujisaki Y; Morikawa N; Takeda Y
    Biol Pharm Bull; 2015; 38(2):235-8. PubMed ID: 25747982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands.
    Rijnders MI; Wolffs PF; Hopstaken RM; den Heyer M; Bruggeman CA; Stobberingh EE
    J Antimicrob Chemother; 2012 May; 67(5):1176-80. PubMed ID: 22290345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Critical Review of the Properties of Fusidic Acid and Analytical Methods for Its Determination.
    Curbete MM; Salgado HR
    Crit Rev Anal Chem; 2016 Jul; 46(4):352-60. PubMed ID: 26337404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antimicrobial findings for fusidic acid tested against contemporary (2008-2009) gram-positive organisms collected in the United States.
    Jones RN; Mendes RE; Sader HS; Castanheira M
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S477-86. PubMed ID: 21546624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusidic acid resistance in Staphylococcus aureus nasal carriage strains in nine European countries.
    den Heijer CD; van Bijnen EM; Paget WJ; Stobberingh EE
    Future Microbiol; 2014; 9(6):737-45. PubMed ID: 25046521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.
    Howden BP; Grayson ML
    Clin Infect Dis; 2006 Feb; 42(3):394-400. PubMed ID: 16392088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections.
    Craft JC; Moriarty SR; Clark K; Scott D; Degenhardt TP; Still JG; Corey GR; Das A; Fernandes P
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S520-6. PubMed ID: 21546629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of fusidic acid in therapy of experimental Staphylococcus aureus meningitis.
    Østergaard C; Yieng-Kow RV; Knudsen JD; Frimodt-Møller N; Espersen F
    J Antimicrob Chemother; 2003 May; 51(5):1301-5. PubMed ID: 12697637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.